Streptococcus pneumoniae DNA initiates type I interferon signaling in the respiratory tract

Dane Parker1, Francis J Martin, Grace Soong

  • 1Department of Pediatrics, College of Physicians and Surgeons, Columbia University, New York, New York, USA. dp2375@columbia.edu

Mbio
|May 19, 2011
PubMed
Abstract

Insights

The bacterium Streptococcus pneumoniae activates type I interferon (IFN) signaling in the airway, crucial for clearing infections. This response, mediated by pneumolysin, highlights IFN

Area of Science:

  • Immunology
  • Microbiology
  • Respiratory Medicine

Background:

  • The mucosal epithelium is the primary defense against respiratory pathogens.
  • Type I interferon (IFN) signaling is traditionally linked to antiviral responses.
  • The sensing mechanisms of the mucosal epithelium against bacterial pathogens remain unclear.

Purpose of the Study:

  • To investigate how the airway mucosal epithelium senses the extracellular bacterium Streptococcus pneumoniae.
  • To determine the role of type I IFN signaling in response to S. pneumoniae infection.
  • To elucidate the bacterial components and host pathways involved in this response.

Main Methods:

  • Utilized mouse models, including wild-type and knockout mice (Tlr4-/-, Myd88-/-, Trif-/-, Nod2-/-, IFN-α/β receptor null).
  • Investigated the role of pneumolysin and bacterial DNA in activating IFN-β expression via the DAI/STING/TBK1/IRF3 pathway.
  • Assessed S. pneumoniae nasal colonization levels in different mouse models.

Main Results:

  • Streptococcus pneumoniae activates the type I IFN cascade in airway epithelial and dendritic cells.
  • Pneumolysin, a pore-forming toxin, is essential for this IFN response.
  • Pneumococcal DNA triggers IFN-β expression through the DAI/STING/TBK1/IRF3 signaling pathway.
  • Mice lacking Tlr4, Myd88, Trif, or Nod2 showed no impairment in type I IFN signaling.
  • Mice lacking the type I IFN receptor exhibited increased S. pneumoniae nasal colonization, indicating impaired clearance.

Conclusions:

  • The type I IFN cascade is a critical component of the mucosal immune response to airway bacterial pathogens like S. pneumoniae.
  • Extracellular bacteria can activate intracellular pattern recognition pathways, typically associated with viral immunity.
  • Pneumolysin and bacterial DNA are key pathogen-associated molecular patterns (PAMPs) that engage intracellular receptors to initiate the type I IFN response.
  • Type I IFNs are essential for controlling S. pneumoniae colonization and facilitating pathogen eradication from the airways.

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...